Cilostazol, naftidrofuryl oxalate, pentoxifylline and inositol nicotinate for the treatment of intermittent claudication in people with peripheral arterial disease

Technology appraisal guidance
Reference number: TA223
Published: 25 May 2011

Appendix A - Decision paper presented to the Institute's Guidance Executive

Appendix A - Decision paper presented to the Institute's Guidance Executive

Appendix A - Decision paper presented to the Institute's Guidance Executive
14 July 2014
(98.07 Kb 28 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 13 July 2014